Zelira Therapeutics Ltd (ASX:ZLD) (OTCMKTS:ZLDAF) has formed an oral care products subsidiary to commercialise scientifically formulated, hemp-derived cannabinoid-based oral care products in the USA.

The first oral care product will be a cannabinoid-containing proprietary toothpaste formulation developed by Sprinjene CEO and founder Dr Sayed Ibrahim.

Zelira Therapeutics forms subsidiary to launch hemp-derived oral care products in the USA